Lupin launches Digital Asthma Educator platform

07 Jun 2021 Evaluate

Lupin has launched Digital Asthma Educator platform. The platform guides asthma patients on the correct technique of using inhalers. The new platform is the latest initiative under Lupin’s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailments.

According to estimates, India has nearly 35 million people living with asthma, including children. While there is no cure for Asthma, it is manageable with proper treatment, vigilance, drug adherence and regular medical checks, thus enabling patients to lead a normal life. Studies have revealed that incorrect use of inhalers often inhibits effective treatment of chronic respiratory ailments, leading to poor clinical control and eventually poor patient health outcome. Hence, it is important for patients to learn correct inhalation technique for better management of the respiratory ailment. 

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2090.15 -23.95 (-1.13%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×